Manufacture of basic pharmaceutical products and pharmaceutical preparations: highest published revenue
95 Belgian companies in the sector (NACE 21) publish their revenue in recent accounts; here are the top 20. Janssen Pharmaceutica leads with €21.8bn (financial year 2025).
Top 20
Ranked by revenue published in the latest filed accounts (accounts less than 3 years old).
| # | Company | Total assets | Revenue | Equity | FTE | Year |
|---|---|---|---|---|---|---|
| 1 | Janssen Pharmaceutica 2340 Beerse | €21.6bn | €21.8bn | €11.7bn | 5,324.5 | 2025 |
| 2 | GlaxoSmithKline Biologicals 1330 Rixensart | €17.8bn | €7.44bn | €9.98bn | 8,371.0 | 2025 |
| 3 | UCB Pharma 1070 Anderlecht | €20.7bn | €4.62bn | €16.2bn | 1,960.6 | 2025 |
| 4 | UCB Biopharma 1070 Anderlecht | €7.15bn | €2.04bn | €1.18bn | 1,395.2 | 2025 |
| 5 | PHOENIX Pharma Belgium 1200 Woluwe-Saint-Lambert | €235.4m | €1.33bn | €46.5m | 496.7 | 2026 |
| 6 | Pfizer Manufacturing Belgium 2870 Puurs-Sint-Amands | €2.46bn | €1.02bn | €1.89bn | 4,020.8 | 2025 |
| 7 | Ajinomoto Omnichem 9230 Wetteren | €476.3m | €468.2m | €323.9m | 863.4 | 2026 |
| 8 | Genzyme Flanders 2440 Geel | €1.00bn | €457.2m | €862.1m | 990.1 | 2025 |
| 9 | Roche 1070 Anderlecht | €164.7m | €448.8m | €64.5m | 122.7 | 2025 |
| 10 | Baxalta Belgium Manufacturing 7860 Lessines | €713.1m | €374.2m | €560.0m | 1,196.8 | 2026 |
| 11 | Pfizer 1050 Ixelles | €377.4m | €358.3m | €129.1m | 297.0 | 2025 |
| 12 | Organon Heist 2220 Heist-op-den-Berg | €349.6m | €287.4m | €235.2m | 1,004.9 | 2025 |
| 13 | Novartis Manufacturing 2870 Puurs-Sint-Amands | €285.2m | €256.5m | €148.4m | 980.0 | 2025 |
| 14 | Novo Nordisk Production Belgium SA 1120 Brussels | €153.5m | €246.3m | €74.2m | 587.2 | 2025 |
| 15 | Telix Innovations 4040 Herstal | €473.4m | €243.8m | €116.7m | 19.8 | 2025 |
| 16 | JNTL Consumer Health (Belgium) 2000 Antwerp | €156.0m | €217.6m | €133.4m | 23.1 | 2025 |
| 17 | Alcon Laboratories Belgium 2870 Puurs-Sint-Amands | €107.2m | €169.7m | €26.6m | 401.8 | 2025 |
| 18 | PolyPeptide 1420 Braine-l'Alleud | €331.7m | €156.1m | €103.8m | 485.0 | 2025 |
| 19 | Molnlycke Health Care 4300 Waremme | €42.1m | €123.2m | €14.5m | 299.5 | 2025 |
| 20 | Laboratoires S.M.B. 1080 Molenbeek-Saint-Jean | €261.5m | €112.5m | €172.9m | 40.0 | 2025 |
These are the revenue figures published in the annual accounts. Small companies (micro and abridged accounts) do not have to publish theirs: they do not appear in this ranking.
← The whole Manufacture of basic pharmaceutical products and pharmaceutical preparations sector
Frequently asked questions
Which company in Manufacture of basic pharmaceutical products and pharmaceutical preparations has the highest revenue?
Janssen Pharmaceutica, with €21.8bn in revenue (financial year 2025).
How many Manufacture of basic pharmaceutical products and pharmaceutical preparations companies publish their revenue?
95 out of 579, in accounts less than 3 years old. Small companies (micro and abridged accounts) are not required to publish it.
Analyse companies in Manufacture of basic pharmaceutical products and pharmaceutical preparations
Filter these companies by size, soundness and trend, follow them and get an alert when their accounts or publications change.
Open the full file →Active companies (legal entities) that have filed at least one set of annual accounts, based on the Crossroads Bank for Enterprises and the National Bank of Belgium. The sector is the main activity in the register; the municipality is that of the registered office. Data updated on 12 Nov 2026.